VAL-083 is effective in patients with newly-diagnosed MGMT-unmethylated glioblastoma: report of phase II study

VAL-083 (30 mg/m<sup>2</sup>/day) combined with radiation therapy was generally safe and well tolerated. Adverse events aligned with previous studies. This regimen, compared to standard-of-care TMZ, showed potential benefits in terms of disease progression and overall survival. Trial registration ClinicalTrials.gov ID NCT03050736, dated: February 13, 2017.

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2025-12-12
DOI
https://doi.org/10.1007/s12672-025-04235-y
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

VAL-083 is effective in patients with newly-diagnosed MGMT-unmethylated glioblastoma: report of phase II study

Ke Sai, Fuhua Lin, Jeffrey Bacha, Shaoyan Xi et al.
Discover Oncology
Glioma Diagnosis and Treatment
article

VAL-083 is effective in patients with newly-diagnosed MGMT-unmethylated glioblastoma: report of phase II study

Ke Sai, Fuhua Lin, Jeffrey Bacha, Shaoyan Xi, Ziyu Dai, Claire Kwan, Xiaoling Qiu, Xiaojing Du, Wanming Hu, John Langlands, Yanchun Lv, Qunying Yang, Zhenghe Chen, Dennis Brown, Richard Schwartz, Sarath Kanekal, Ji Zhang, Xi Cao, Chao Ke, Yixiang Liao, Zhihuan Zhou, Glyn Johnson, Jiawei Li, Chengcheng Guo, Shaoxiong Wu, Zhongping Chen, Meiling Deng
article en

Abstract

VAL-083 (30 mg/m<sup>2</sup>/day) combined with radiation therapy was generally safe and well tolerated. Adverse events aligned with previous studies. This regimen, compared to standard-of-care TMZ, showed potential benefits in terms of disease progression and overall survival. Trial registration ClinicalTrials.gov ID NCT03050736, dated: February 13, 2017.

Discover OncologyVol. 17(1)
Sun Yat-sen University (CN), Vale (Brazil) (BR), Technology Holding (United States) (US), Delmar (Canada) (CA), Sun Yat-sen University Cancer Center (CN), Applied Sciences Laboratory (United States) (US)
Openalex Percentile: Top 40%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.